KZIA Kazia Therapeutics ADRs

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:KZA.

$0.97  0.00 (0.00%)
As of 03/24/2023 00:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  Australia
IPO date:  02/11/2013
Outstanding shares:  22,802,911
Average volume:  70,228
Market cap:   $21,747,136
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%